SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-19-064731
Filing Date
2019-11-15
Accepted
2019-11-15 16:01:41
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm1923062d1_sc13g.htm SC 13G 62402
2 EXHIBIT 1 tm1923062d1_ex-1.htm EX-99.1 5697
3 EXHIBIT 2 tm1923062d1_ex-2.htm EX-99.2 6211
4 EXHIBIT 3 tm1923062d1_ex-3.htm EX-99.3 6891
  Complete submission text file 0001104659-19-064731.txt   82902
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 191224494
SIC: 2834 Pharmaceutical Preparations